The News Review:
- … Inc. Promotes Rebecca Li Ph.D. to Vice President of…
- New Independent Research Study Indicates That Cylex’s ImmuKnow…
- Research hits the bull’s eye now for the cost
… Inc. Promotes Rebecca Li Ph.D. to Vice President of…
Free with registration – Business Wire – AccessMyLibrary.com – Feb 20, 2008
Promotes Rebecca Li Ph. to Vice President of Clinical Research. (20-FEB-08) Business Wire. Promotes Rebecca Li Ph. to Vice President of Clinical Research.
New Independent Research Study Indicates That Cylex’s ImmuKnow…
Free with registration – PR Newswire – AccessMyLibrary.com – Feb 20, 2008
today announced the publication of an independent peer reviewed clinical research study in which the level of cellular immune response measured prior to kidney transplantation using the Company’s proprietary ImmuKnow(R) immune cell function test was found to identify patients that may be at risk for early acute transplant rejection and unstable kidney function in the first three months following transplantation. The results of this independent clinical research study which was authored by members of the kidney transplant programs at Duke University.
Research hits the bull’s eye now for the cost
Nation Multimedia – Feb 20, 2008
The guiding advice was also enshrined as part of the philosophy of Mahidol University. ur mission covers not only medical care but teaching training and research in the quest for innovations. There's no doubt clinical research has a great impact on the development of medical care. Yet often research studies never give rise to an appropriate therapy or medicine. Indeed for a majority of the findings in basic and molecular research there is no beneficial outcome for the community. But if it weren't for the curiosity and enthusiasm of scientists – some of them taking years or even their whole lives to discover one valuable thing – there would be no progress. Targeted therapy in breast cancer is one of the best examples of a new treatment derived from a great effort of a group of scientists.
